Analyst Reco.

Jun. 01 BIONTECH : Buy rating from Jefferies ZD
May. 27 BioNTech's Cancer Pipeline Seen Strengthening Ahead of Key Trial Results, UBS Says MT
May. 27 BIONTECH : From Neutral to Buy by UBS ZD
May. 27 UBS Upgrades BioNTech to Buy From Neutral, Adjusts Price Target to $135 From $117 MT
May. 22 Bernstein Initiates Coverage on BioNTech With Market Perform Rating MT
May. 12 Berenberg Lowers Price Target on BioNTech to $140 From $155, Keeps Buy Rating MT
May. 12 BIONTECH : Receives a Buy rating from Berenberg ZD
May. 05 BioNTech: Though Q1 operations missed expectations, 2026 guidance remained unchanged Alphavalue
Apr. 13 BIONTECH : Berenberg reaffirms its Buy rating ZD
Mar. 25 BIONTECH : Jefferies reiterates its Buy rating ZD
Mar. 17 BIONTECH : Deutsche Bank maintains a Buy rating ZD
Mar. 11 BIONTECH : Gets a Buy rating from Goldman Sachs ZD
Mar. 11 BioNTech: Unjustified panic about the surprising departure of co-founders Alphavalue
Mar. 10 BIONTECH : Buy rating from Jefferies ZD
Mar. 10 BIONTECH : Buy rating from Deutsche Bank ZD
Feb. 02 BioNTech Shares Lower After Leerink Partners Downgrade MT
Feb. 02 Leerink Partners Downgrades BioNTech to Market Perform From Outperform, Adjusts Price Target to $113 From $112 MT
Jan. 23 BIONTECH : Berenberg reiterates its Buy rating ZD
Jan. 16 Goldman Sachs Upgrades AutoNation to Buy From Neutral, Adjusts Price Target to $142 From $115 MT
Dec. 11 Berenberg Raises Price Target on BioNTech to $155 From $150, Keeps Buy Rating MT
Dec. 11 BIONTECH : Berenberg keeps its Buy rating ZD
Dec. 03 BIONTECH : Gets a Buy rating from Jefferies ZD
Nov. 25 BIONTECH : Buy rating from Berenberg ZD
Nov. 17 BIONTECH : Berenberg reiterates its Buy rating ZD
Nov. 12 BIONTECH : Jefferies reiterates its Buy rating ZD
No results match your criteria
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!